Abstract
Previously, many morbidly obese (MO) patients were denied liver transplantation (LT) because of the higher operative risk. However, nowadays, 5 and 10 years graft survival is the rule, and patients whose lives can be prolonged with LT are dying of obesity-related comorbidities. Recent experience suggests that weight reduction in MO liver transplant recipients would improve their long-term survival. The bariatric surgery before LT is contraindicated for patients with decompensated cirrhosis, while post-transplant intervention is associated with increased technical difficulty. We present our experience with three patients who underwent simultaneous liver transplantation and sleeve gastrectomy. After a median 13 months follow-up, all patients are alive, having normal allograft function and significant weight loss. Combined liver transplantation with simultaneous sleeve gastrectomy appears technically feasible and relatively safe in selected patients.
This is a preview of subscription content, log in via an institution to check access.
References
Charlton MR, Burns JM, Pedersen RA, et al. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology. 2011;141:1249–53.
Thuluvath PJ. Morbid obesity with one or more other serious comorbidities should be a contraindication for liver transplantation. Liver Transpl. 2007;13:1627–9.
Mandell MS, Zimmerman M, Campsen J, et al. Bariatric surgery in liver transplant patients: weighing the evidence. Obes Surg. 2008;18(12):1515–6.
Lazzati A, Iannelli A, Schneck AS, et al. Bariatric surgery and liver transplantation: a systematic review a new frontier for bariatric surgery. Obes Surg. 2015;25(1):134–42.
El Atrache MM, Abouljoud MS, Divine G, et al. Recurrence of non-alcoholic steatohepatitis and cryptogenic cirrhosis following orthotopic liver transplantation in the context of the metabolic syndrome. Clin Transpl. 2012;26(5):E505–12.
Sawyer RG, Pelletier SJ, Pruett TL. Increased early morbidity and mortality with acceptable long-term function in severely obese patients undergoing liver transplantation. Clin Transpl. 1999;13(1 Pt 2):126–30.
Mosko JD, Nguyen GC. Increased perioperative mortality following bariatric surgery among patients with cirrhosis. Clin Gastroenterol Hepatol. 2011;9(10):897–901.
Rogers CC, Alloway RR, Alexander JW, et al. Pharmacokinetics of mycophenolic acid, tacrolimus and sirolimus after gastric bypass surgery in end-stage renal disease and transplant patients: a pilot study. Clin Transpl. 2008;22:281–91.
Heimbach JK, Watt KD, Poterucha JJ, et al. Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and endstage liver disease. Am J Transplant. 2013;13:363–8.
Tariciotti L, D’Ugo S, Manzia TM, et al. Combined liver transplantation and sleeve gastrectomy for end-stage liver disease in a bariatric patient: First European case-report. Int J Surg Case Rep. 2016;28:38–41.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Financial Support
None.
Conflict of Interests
The authors declare that they have no conflict of interest.
Ethical Approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Waiver of Informed Consent
For this type of study formal consent is not required.
Additional information
All Affiliated with Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
Rights and permissions
About this article
Cite this article
Nesher, E., Mor, E., Shlomai, A. et al. Simultaneous Liver Transplantation and Sleeve Gastrectomy: Prohibitive Combination or a Necessity?. OBES SURG 27, 1387–1390 (2017). https://doi.org/10.1007/s11695-017-2634-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-017-2634-5